Argentina
Industry
BMI View: Improvements in supply chain technologies in Argentina will contribute to reducing the current high levels of counterfeit medicines. BMI believes the promotion of generic...
2010-08-23Industry
BMI View: With the creation of free trade agreements (FTAs) giving increased access to international markets and the strong growth of domestic demand, South American countries in the...
2010-08-13Companies
The generic drugmaker Eurofarma has further consolidated its presence in the Latin American market with the acquisition of LaborĂ¡torios Gautie - the seventh largest pharmaceutical...
2010-07-05Industry
BMI View: Emerging markets will drive industry growth. The importance of emerging markets to large multinational drugmakers cannot be overstated - BMI's Pharmaceutical Expenditure Model...
2010-06-14Industry
The pharmaceutical sector in Argentina has expressed growing concerns over low profitability. Drug prices are expected to increase by 14.5% during 2010, which is well below the government's...
2010-04-14Industry
Argentina's pharmaceutical market reached a value of ARS12.47bn (US$3.37bn) in 2009, equating to a 2004-2009 compound annual growth rate (CAGR) of 15.74% in local currency terms and...
2010-01-26Industry
Japan's largest drugmaker, Takeda, has announced that it plans to enter the South American drug market via the acquisition of a generic drugmaker in the region, though the company...
2009-11-30Industry
Argentinean President Christina Kirchner Fernandez has announced that local production of a swine flu vaccine will commence in 2010, via a new plant and a partnership between local...
2009-11-24


